the populations were stable and essentially independent of generation time (Fig. 3 ). Denitrifiers and ammonifiers competed for the same substrates and used the same enzyme for nitrate reduction (NapAB) and therefore should have similar affinities for nitrate. This means that the observed selective force of microbial generation time most likely acted on a slight difference in substrate affinity for nitrite, the branching point of the two pathways. Even though specific enzyme affinities have been determined for isolated nitrite reductases, their in vivo affinities are unknown. Apparent substrate affinities are directly proportional to potential rates, and we observed large differences between the potential rates of nitrite reduction of the two pathways, especially when multiple electron donors were provided (Table 1 ). For ammonification, the rates were lower than for denitrification, even leading to the transient accumulation of nitrite during ammonification of nitrate, which was not observed during denitrification ( fig. S6 ). Lower rates with multiple electron donors might be explained by a bottleneck in electron supply to the nitrite reductases of ammonification. These require six electrons per nitrite, versus only a single electron for denitrification.
In all experiments reported so far, nitrate or nitrite were in limited supply in the presence of a slight excess of carbon substrates. According to previous studies (2) (3) (4) (5) , carbon limitation in the presence of excess nitrate should favor denitrification. To investigate this idea in the present experimental context, we performed a continuousculture incubation under carbon limitation with excess nitrate. A shorter generation time and a supply of nitrite instead of nitrate were tested in two parallel control experiments. In all three cases, denitrification became the prevalent pathway ( fig. S7 ), confirming the importance of carbon/ nitrogen ratio in addition to generation time and supply of nitrite relative to nitrate. Finally, we investigated the potential effect of temperature on the competition by determining the apparent activation energy (E a ) and the Q10 temperature coefficient for both processes (Table 1 and fig. S8 ). The calculated coefficients were not significantly different (F 2,18 = 1.93, P = 0.174); thus, we were not able to reproduce a previously observed effect of temperature on the competition between two bacterial isolates (9) .
Generation time, nitrate versus nitrite supply, and carbon/nitrogen ratio completely and reproducibly explained the fate of nitrate in 21 experimental trials with a microbial community sampled from a marine tidal flat. For these factors to hold such strong selective pressure, it is conceivable that the conditions favored the selected populations for reasons that are unrelated to nitrate respiration and cannot be extrapolated to other habitats. However, the combined results show that denitrifying and ammonifying populations were competing for the same electron donors (mainly organic acids, formate, hydrogen, and sulfide; Fig. 3 ) provided by the same fermentative populations. Further, selective pressure of pH, copper, presence of sulfide, supply of fermentation products, natural seawater and temperature could be ruled out on the basis of independent experiments ( Fig. 1 and fig. S8 ). Instead, the results suggest that the selective force acted directly on the nitrite reductases. A slightly higher apparent affinity for nitrite of the cytochrome cd 1 nitrite reductases of denitrification would explain the observed higher fitness of denitrification with nitrite as the electron acceptor and at shorter generation times. With nitrate, when the generation time is short, NrfA/OCC cannot keep up with the nitrate reductase ( fig. S6) In accord with these dual actions of 25-HC, Ch25h-deficient mice exhibit increased sensitivity to septic shock, exacerbated experimental autoimmune encephalomyelitis, and a stronger ability to repress bacterial growth. These findings identify an oxysterol, 25-HC, as a critical mediator in the negative-feedback pathway of IFN signaling on IL-1 family cytokine production and inflammasome activity.
A s well as having potent antiviral activity, type I interferon (IFN) has a suppressive influence on immunity, an action that helps prevent uncontrolled inflammation and that underlies its utility in treatment of certain autoimmune diseases, such as multiple sclerosis (1) (2) (3) (4) . This suppressive action also contributes to the increased propensity for bacterial infection after viral infection (1, 2) . A central facet of the IFN-mediated suppressive effect is down-regulation of inflammasome activity and interleukin-1b (IL-1b) production (3, 5) . However, which of the several hundred IFN-stimulated genes are responsible for these effects is poorly SCIENCE sciencemag.org defined. The IFN-stimulated gene cholesterol 25-hydroxylase (Ch25h) (6) was recently shown to have broad antiviral activity (7, 8) , but whether this gene has an anti-inflammatory role is unknown.
Ch25h is an enzyme that hydroxylates cholesterol at the 25 position to generate 25-hydroxycholesterol (25-HC) (9) . Ch25h is strongly induced in myeloid cells by Toll-like receptor (TLR) ligands in a type I IFN-dependent manner (10) . Recently, we and others identified a role for a downstream product of Ch25h, 7a,25-dihydroxycholesterol (7a,25-HC), as a ligand for EBI2 (GPR183) (11, 12) . During studies comparing Ch25h-and EBI2-deficient mice, we found that Ch25h -/-mice had increased frequencies of IL-17A + T cells in spleen and lymph nodes (Fig. 1A) . The frequencies of IFN-g-producing and regulatory T cells were unaffected ( fig. S1A ). Ch25h-deficient mice also had increased neutrophil counts (Fig. 1B) , a phenotype seen in other strains with elevated IL-17A + cells (13, 14) . Gpr183
-/-mice were not affected in these parameters (fig. S1B). These data indicated that Ch25h was acting via an EBI2-independent pathway to regulate IL-17A + T cell and neutrophil numbers, two cell populations that often promote inflammation.
Because Ch25h can be expressed at high levels in activated macrophages (7, 8, (15) (16) (17) , we asked whether the IL-17A-polarizing activity of lipopolysaccharide (LPS)-stimulated macrophage cultures was altered by Ch25h deficiency. Culture supernatants from Ch25h-deficient macrophages induced more IL-17A + T cells than supernatants from control macrophages (Fig. 1C and fig. S1 , C and D). T helper 1 (T H 1) and T H 2 cell differentiation were unaffected (Fig. 1C and fig. S1C ). As expected, LPS stimulation of bone marrowderived macrophages (BMDMs) caused Ch25h induction in an IFN-a receptor (IFNaR)-dependent manner (fig. S1E), and this was associated with increased 25-HC in culture supernatants ( fig. S1F ). However, when 25-HC was added to T cell cultures at this concentration (100 nM), it was without effect ( fig. S1G ). These data suggested that the Ch25h -/-and control macrophage culture supernatants were differing in some other constituent that affected T H 17 cell differentiation. Cytokines that synergize with transforming growth factor-b (TGFb) to induce T H 17 cells include IL-1b, IL-23, and IL-6 (18). Analysis after LPS stimulation revealed that Il1b was transiently overproduced in Ch25h-deficient macrophages, whereas Il6 and Il23 were unaltered ( Fig. 2A) . LPS stimulated EBI2-deficient BMDMs had wild-type amounts of Il1b ( fig. S2A ). Activated BMDMs lacking Cyp7b1, the enzyme that converts 25-HC to 7a,25-HC, also produced normal Il1b levels (fig. S2A), and their culture supernatants contained unaltered amounts of 25-HC ( fig. S2B ), consistent with minimal Cyp7b1 expression in BMDMs ( fig. S2C ). Flow cytometric analysis showed elevated pro-IL-1b in Ch25h-deficient compared with wild-type macrophages (Fig. 2B) . Confirming the presence of secreted IL-1b, IL-17A induction by Ch25h-deficient macrophage supernatants required T cell IL-1 receptor (IL-1R) expression ( fig. S2D ). The Il1b elevation in Ch25h -/-BMDMs occurred without a change in transcript stability and was preceded by induction of precursor mRNA, which indicated that it was due to increased transcription (Fig. 2C ). IL-1b secretion occurs after cleavage of pro-IL-1b by the inflammasome-activated protease caspase-1 (19) . LPS treatment causes inflammasome priming by up-regulating expression of Casp-1, Nlrp3, and Asc (19) , and induction of these transcripts occurred normally in Ch25-deficient BMDMs ( fig. S2E ). Full inflammasome activation depends on exposure to an activating agent, such as adenosine triphosphate (ATP) (19) . IL-1b was elevated in the supernatant of LPS-stimulated Ch25h -/-BMDMs exposed to ATP (Fig. 2D ), whereas IL-6 was unaffected ( Fig. 2D ), and IL-23 was too low for measurement by enzyme-linked immunosorbent assay. LPS-stimulated Ch25h-deficient BMDMs also overproduced IL-18, another caspase-1-dependent IL-1 family member (19) (Fig. 2D ). The increased secretion of IL-18 occurred in the absence of any transcript level differences ( fig. S2F ), which suggested that Ch25h-deficient BMDMs had elevated inflammasome activity. Type I IFN inhibits NLRP3-containing inflammasomes by an undefined mechanism (2, 4, 5).
LPS-primed Ch25h-deficient BMDMs exposed to ATP showed exaggerated caspase-1 activity, compared with equivalently treated control macrophages (Fig. 2 , F and G), and generated more processed IL-1b (Fig. 2H) . A slight elevation in caspase-1 activity was evident in Ch25h -/-macrophages not exposed to ATP (Fig. 2 , F and G), consistent with the elevated IL-1b bioactivity in these supernatants (Fig. 1C) . Increased caspase-1 activity in Ch25h-deficient BMDMs was also observed after treatment with the additional NRLP3-inflammasome activators nigericin and alum, the NLRP4-inflammasome activator flagellin, and the AIM2-inflammasome activator poly (deoxyadenylic-deoxythymidylic) acid [poly(dA:dT)] (Fig. 2I ). This broad inflammasome-repressive action of Ch25h suggests that it acts across nucleotide-binding oligomerization domain-like receptors (NLRs) or at a site downstream of the NLRs.
To test whether the Ch25h product was sufficient to regulate Il1b expression and caspase-1 activation, LPS-treated BMDMs were incubated with 25-HC. 25-HC suppressed Il1b mRNA, protein expression, and inflammasome activity in Ch25h-deficient cells, such that the amounts induced were similar to endogenously 25-HCproducing control cells (Fig. 3A and fig. S3A ). 25-HC had no significant effect on ll6 expression ( fig. S3A) represents cells from an individual mouse, and data are pooled from more than 10 experiments. *P < 0.05; **P < 0.01, ***P < 0.005 (unpaired Student's t test).
did not cause any change in Il1b levels or protein expression (Fig. 3A) . Moreover, although transduction of both control and Ch25h-deficient BMDMs with wild-type Ch25h repressed Il1b expression and inflammasome activity, transduction with a point mutant that lacks enzymatic function (20) did not ( Fig. 3B and fig. S3C ). 25-HC is one of several oxysterol ligands for the nuclear hormone receptors, liver X receptor-a (LXRa, encoded by Nr1h3) and LXRb (Nr1h2) (21, 22) , which can negatively regulate Il1b expression (23) (24) (25) (26) . However, whether 25-HC has a physiological role as an LXR ligand remains unclear (27, 28) . We did not observe any overinduction of Il1b transcripts, intracellular pro-IL-1b, or secreted SCIENCE sciencemag.org IL-1b after LPS exposure of macrophages generated from LXR-deficient (Nr1h2
) mice compared with those from control bone marrow (BM) (fig. S3D) . Moreover, transduction of LXR-deficient cells with Ch25h led to a similar repression in IL-1b production to that observed with control BMDMs (fig. S3E ). These observations suggest that 25-HC acts via an LXR-independent mechanism to regulate Il1b transcription.
In vitro, 25-HC can repress sterol response element-binding protein (SREBP) processing into active transcription factors, which are required for cholesterol biosynthesis (29, 30) (fig.  S3F ). However, Ch25h-deficient mice have intact cholesterol metabolism, which makes it unclear whether 25-HC has a physiological role as a negative regulator of SREBP processing and, therefore, sterol biosynthesis (9, 28). To further explore how Ch25h might regulate Il1b expression and inflammasome activity, we performed RNA sequencing (RNAseq) on LPS-treated BMDMs. This analysis revealed a striking elevation in transcripts for SREBP target genes in Ch25h -/-macrophages ( Fig. 3C and fig. S3G ). It also confirmed the elevation in Il1b and showed that Il18, Il6, and tumor necrosis factor (Tnf) were not greatly changed ( fig. S3H) S3I ). Nr1h2 -/-3 -/-macrophages showed little alteration in the expression of SREBP target genes ( Fig. 3C and fig. S3H ). Western blotting confirmed that Ch25h deficiency was sufficient to deregulate SREBP processing in activated BMDMs ( fig. S3J ). These data implicate repression of SREBPs as a major pathway of gene regulation by 25-HC in activated macrophages. Sterol biosynthesis is down-regulated in IFN-exposed cells (7, 31) , and our findings suggest that Ch25h is a key IFN-induced gene responsible for this repression. (32) (fig. S3F ). To test whether 25-HC-mediated suppression of Il1b could be explained by activation of INSIG, we took advantage of the observation that INSIG overexpression is sufficient to inhibit SREBP processing even without addition of a ligand (32) . Indeed, INSIG1 overexpression in Ch25h-deficient BMDMs led to reductions in LPSstimulated Il1b transcripts and pro-IL-1b levels, whereas expression of Il6 was unaffected (Fig.  3D) . In a second approach, we examined macrophages lacking the SREBP-cleavage-activating protein (SCAP) that is required for transport of SREBPs from the ER to the Golgi for processing (32) (fig. S3F ). SCAP-deficient BMDMs expressed reduced amounts of Il1b and underwent reduced caspase-1 activation (Fig. 3E) . These data indicate that repression of SREBP processing contributes to the mechanism of 25-HC-mediated downregulation of Il1b and inflammasome activity.
25-HC antagonizes processing of SREBP-1 and -2 by promoting their insulin-induced gene (INSIG)-mediated retention in the endoplasmic reticulum (ER), out of reach of activator proteases in the Golgi
To test whether IL-1 family cytokine production was regulated by Ch25h in vivo, mice were treated with LPS. After a sublethal LPS dose, Ch25h-deficient mice had more IL-1b and IL-18 in serum compared with controls ( Fig. 4A and fig.  S4A ). IL-1a, a cytokine that is often coreleased with IL-1b (33), was also increased (fig. S4A) . Serum IL-6 levels were unaffected ( fig. S4B) , and TNF was too low to measure. Splenic macrophages from the knockout mice showed deregulated expression of several SREBP-target genes ( fig. S4C) . BM chimera analysis established that Ch25h was required in hematopoietic cells for regulation of IL-1b and IL-1a and that both hematopoietic and stromal cell Ch25h regulated  IL-18 (fig. S4, D and E) . Overexpression of Ch25h in hematopoietic cells led to elevated baseline 25-HC in serum ( fig. S4F ) and to reduced IL-1b production after LPS treatment ( fig. S4G) . After exposure to a lethal LPS dose, Ch25h-deficient mice succumbed~12 hours sooner than controls (Fig. 4B) . Although it is recognized that LPS-induced death is influenced by factors besides IL-1 family cytokines, these data establish the important role of this single enzyme in resisting the lethal impact of septic shock ( fig. S4H) . We also tested the effect of Ch25 deficiency on the course of myelin oligodendrocytes glycoprotein (MOG)-induced EAE, an IL-17-driven inflammatory disease (2) . In accord with increased IL-17A + cell generation and with evidence that IL-1b contributes to central nervous system pathology in this model (4), Ch25h-deficient mice suffered from exacerbated disease compared with controls (Fig. 4C) .
Macrophage infection by the bacterium Listeria monocytogenes induces type I IFN and Ch25h expression, and bacterial replication in liver and spleen is promoted by type I IFN signaling (1, 2) . Ch25h-deficient mice were more resistant to Listeria growth than littermate controls (Fig. 4D) ; IL-1b, IL-1a, and IL-18 were elevated in the serum of infected mice ( fig. S5A ) and in BMDMs (fig.  S5B) ; and the macrophage supernatants induced greater IL-17A + T cell differentiation ( fig. S5C ). Bacterial growth in BMDMs initially occurred at the same rate and then became more strongly repressed in Ch25h-deficient cells (fig. S5D ). Although there is not yet a consensus on the mechanism of IFNaR-mediated augmentation of Listeria growth (1, 2), our data indicate that type I IFNmediated Ch25h induction contributes to host susceptibility to bacterial infection ( fig. S5E) .
Neutrophil recruitment to the peritoneum in response to the inflammasome activator, alum, is IL-1b-dependent (5). After treatment with alum alone, Ch25h-deficient and wild-type mice showed similar amounts of neutrophil recruitment (Fig.  4E) . However, Ch25h-deficient mice suffered an inability to suppress neutrophil recruitment after type I IFN induction by poly(I:C) treatment (Fig.  4E) . Similar findings were made in Ch25h-deficient BM chimeras (fig. S5F ). Six hours after poly(I:C) treatment, wild-type mice showed a 20-fold increase in 25-HC serum concentrations (Fig. 4F) . These data indicate that 25-HC functions downstream of type I IFN to repress IL-1b-mediated peritoneal inflammation (fig. S5E ).
We identify Ch25h as an essential part of the negative-feedback mechanism regulating IL-1 family cytokine production during inflammatory conditions involving type I IFN. 25-HC functions as a repressor of Il1b expression and as a broad inhibitor of inflammasome activity. Our findings support a model where 25-HC engagement of INSIG and antagonism of SCAP-dependent SREBP processing reduces Il1b expression and inflammasome activity. We speculate that repression of SREBP decreases Il1b expression and inflammasome activity by reducing cellular content of key sterols, possibly including cholesterol itself. 25-HCmediated feedback regulation of inflammation requires multiple steps ( fig. S3F) , and we suggest that this serves as a built-in delay to allow adequate IL-1 family cytokine production and inflammasome activation before repression occurs. The anti-inflammatory actions of 25-HC defined in this study reveal a pathway that may contribute to the therapeutic activity of type I IFN in treatment of inflammasome-dependent autoimmune disease (4), the successful use of type I IFN in treatment of some types of cancer (1), and the widespread occurrence of uncontrolled bacterial infection after viral infection (1, 2) ( fig. S5E) . Elongation factor 4 (EF4/LepA) is a highly conserved guanosine triphosphatase translation factor. It was shown to promote back-translocation of tRNAs on posttranslocational ribosome complexes and to compete with elongation factor G for interaction with pretranslocational ribosomes, inhibiting the elongation phase of protein synthesis. Here, we report a crystal structure of EF4-guanosine diphosphate bound to the Thermus thermophilus ribosome with a P-site tRNA at 2.9 angstroms resolution. The C-terminal domain of EF4 reaches into the peptidyl transferase center and interacts with the acceptor stem of the peptidyl-tRNA in the P site. The ribosome is in an unusual state of ratcheting with the 30S subunit rotated clockwise relative to the 50S subunit, resulting in a remodeled decoding center. The structure is consistent with EF4 functioning either as a back-translocase or a ribosome sequester.
P rotein biosynthesis by the ribosome is facilitated at multiple stages by translational guanosine triphosphatases (trGTPases) that catalyze the hydrolysis of guanosine 5′-triphosphate (GTP) to promote conformational changes that lead to transitions between ribosome functional states (1). One of the critical and complex steps in protein synthesis is elongation, a unidirectional sequence of events catalyzed by elongation factor Tu (EF-Tu), which delivers an aminoacyl-tRNA to the ribosomal A site in response to the codon displayed on the mRNA, and elongation factor G (EF-G), which promotes the movement of tRNAs in the A and P sites to the P and E sites, respectively, in a process called translocation. During these highly dynamic events, tRNAs transit through the ribosome with a concomitant counterclockwise ratchetlike movement of the 30S subunit (2-4). Through multiple rounds of amino acid incorporation to the nascent peptide chain and tRNA translocation, the ribosome translates the genetic information in the mRNAs into proteins.
Under certain conditions, factors that are not required for normal elongation intervene in the elongation cycle to perform special functions (5-7). Elongation factor 4 (EF4), encoded by the lepA gene in Escherichia coli (8) , is one such factor that is a highly conserved GTPase found in bacteria as well as in the mitochondria and chloroplasts of eukaryotes (9, 10) . EF4 is known to have a ribosome-dependent GTPase activity (9, 11, 12) and to increase the rate of protein synthesis at high intracellular ionic strength (13) but has no effect on translational accuracy (13, 14) . It also promotes tRNA back-translocation on posttranslocation (POST) ribosomal complexes with tRNAs in the E and P sites (9, 11, 12, 15) , thus reverting the reaction mediated by EF-G. An alternate model, based on single-molecule Förster resonance energy transfer (smFRET) experiments, suggests that EF4 effectively competes with EF-G for binding to the pretranslocational (PRE) state of the ribosome with tRNAs in the A and P sites, sequestering ribosomes in an intermediate state, leading to a transient inhibition of the elongation cycle (16) .
EF4 has six domains, of which four (I, II, III, and V) are homologous to corresponding domains in EF-G (Fig. 1) (17) . It differs from EF-G by having a short domain IV and lacking a G′ subdomain, but possessing a conserved C-terminal domain (CTD) (17) . The last 44 residues of the CTD are flexible and therefore not visible in the crystal structure of ribosome-free EF4 (17) . A prior cryo-electron microscopy (cryo-EM) reconstruction showed that EF4 has the same binding site on the ribosome as that of other trGTPases and affects the conformation of the A-site tRNA (12) . However, the low resolution of this cryo-EM map limits the conclusions that can be drawn from it about the structure and function of EF4 on the ribosome.
Structure determination of GTPase translation factors bound to the ribosome has remained a challenge (18) . Using a new approach to crystallize trGTPases on the ribosome that covalently links the N-terminal domain of ribosomal protein L9 to the trGTPase ( fig. S1 ) (19), we report a 2.9 Å resolution crystal structure of a complex between the Thermus thermophilus 70S ribosome and EF4 with guanosine diphosphate (GDP) bound. The structure shows that the CTD of EF4 reaches into the peptidyl transferase center (PTC) of the 50S subunit and reveals details of the interactions of the CTD with the acceptor stem of the peptidyl-tRNA in the P site and other elements of the PTC. In contrast to the counterclockwise ratcheting motion of the 30S subunit previously observed during EF-Gmediated tRNA translocation (4, (20) (21) (22) , the 30S subunit in our EF4-ribosome complex is rotated clockwise, which results in a remodeled decoding center.
The initial phase of the diffraction data obtained by using a model of an empty ribosome showed clear unbiased electron density for the mRNA, Phe-tRNA Phe in the P site, EF4 with its CTD near the acceptor stem of the Phe-tRNA Phe in the P site, and for the phenylalanine residue attached to the P-site tRNA in the difference Fourier map (Fig. 1) (19) . Residual electron density was observed in the E site, where a tRNA Phe was modeled. The overall conformation of EF4-GDP bound to the ribosome seen in our structure is in agreement with the cryo-EM reconstruction reported for the complex of EF4-GDPNP with the ribosome (Fig. 1, fig. S2 , and movie S1) (12) and is similar to that seen in the crystal structure of ribosome-free EF4 (17) . Binding of EF4 to the ribosome affects the position of its domain V, which is displaced by more than 13 Å and rotated by~30°to avoid a steric collision with the sarcin-ricin loop (SRL) of the 50S subunit ( fig. S3 ). EF4 contacts both ribosomal subunits (Fig. 1A) and is held in position by interactions that are analogous to the ones previously reported for EF-G in complex with the ribosome (figs. S4 and S5) (23) .
The terminal residues of the CTD form two a-helices (a1 and a2) connected by a short turn, resulting in a helix-turn-helix (HTH) module that occupies the A site of the 50S subunit and reaches
